Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Pelvic Insufficiency Fractures in Cervical Cancer
NCT07245381Phase 2Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of alendronate in pelvic insufficiency fracture. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
alendronate
03
Conditions
pelvic insufficiency fracture
Beyond the preview
Go deeper on NCT07245381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245381.